Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

CLDX holding history

Celldex Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLDX overviewAll 13F holders of CLDXFull Q2 2026 holdings

Shares (Q2 2026)
1,073,985
Value
$40.0M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of CLDX by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,073,985$40.0M<0.1%+14,451+1.4%AddedHolders
Q1 20261,059,534$33.6M<0.1%+407,818+62.6%AddedHolders
Q4 2025651,716$17.7M<0.1%+394,633+153.5%AddedHolders
Q3 2025257,083$6.65M<0.1%+113,197+78.7%AddedHolders
Q2 2025143,886$2.93M<0.1%+143,886NewHolders
Q2 20240$00.0%−43,431−100.0%Sold outHolders
Q1 202443,431$1.82M<0.1%−187,040−81.2%ReducedHolders
Q4 2023230,471$9.14M<0.1%−110,879−32.5%ReducedHolders
Q3 2023341,350$9.39M<0.1%−112,284−24.8%ReducedHolders
Q2 2023453,634$15.4M<0.1%−45,120−9.0%ReducedHolders
Q1 2023498,754$17.9M<0.1%−2,322−0.5%ReducedHolders
Q4 2022501,076$22.3M<0.1%−33,439−6.3%ReducedHolders
Q3 2022534,515$15.0M<0.1%−77,357−12.6%ReducedHolders
Q2 2022611,872$16.5M<0.1%+19,514+3.3%AddedHolders
Q1 2022592,358$20.2M<0.1%+142,761+31.8%AddedHolders
Q4 2021449,597$17.4M<0.1%+90,963+25.4%AddedHolders
Q3 2021358,634$19.4M<0.1%−790−0.2%ReducedHolders
Q2 2021359,424$12.0M<0.1%+56,072+18.5%AddedHolders
Q1 2021303,352$6.25M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.